Webinar Archives - SCN2A Australia

Clinical Features of SCN2A-Related Disorders

David Cunnington
February 16, 2020
Webinar
0 Comments

Mutations of the SCN2A gene can result in a range of different clinical syndromes. Understanding these clinical presentations can help to guide treatment.

Developing Treatment for SCN2A

SCN2A Australia
November 23, 2019
Webinar
0 Comments

Prof Steven Petrou and Dr Kiran Reddy discuss the RC-222 program developing an ASO treatment for gain-of-function SCN2A epilepsies.

Facebook Posts

SCN2A Australia

2 days ago

JOIN OUR SCN2A TEAM..

Click on the link below to join our team or donate to the SCN2A fundraiser.

We thank the Epilepsy Foundation of Australia for facilitating this fundraiser

We have had to change the way we raise awareness and funds and advocate. We invite you to join us as we 'Walk for Epilepsy' around Australia.

Over 25 days in October, we’ll walk, swim, run and cycle our way to 25,000 kilometres to raise awareness for the 1 in 25 Australians living with epilepsy.

Home isolation has given Australians a new window into what life can be like for people living with epilepsy. Stigma and uncertainty mean many people are forced to stay at home, something Australians are all too familiar with amid the coronavirus pandemic.

Register Now!
That’s why we’re making the Walk for Epilepsy bigger than it’s ever been before - by taking it online. No matter when, where or how you walk, your contribution will go straight towards our target, which covers the 25,000 kilometres that line Australia’s coast.

Set your own goal, team up with family, friends or colleagues and raise vital funds to support people living with epilepsy. Together, we can make sure no one has to go it alone.

For more info, to register or to donate, please click this link: fundraising.epilepsyfoundation.org.au/fundraiser/scn2a

All funds will go towards the mission of our organisation.

#SCN2A #cureSCn2A

SCN2A - Australia, NZ and Asia ... See MoreSee Less

Photo

View on Facebook

SCN2A Australia

7 days ago

Exciting science on SCN2A for gain of function presentations. Prof. Steve Petrou and his team trialed a ASO on mice models and saw positive outcomes

"This study suggests that a human SCN2A (gapmer) ASO could profoundly and safely impact early seizure onset DEE patients and heralds a new era of precision therapy in neurodevelopmental disorders."

#SCN2A #ASO #cureSCN2A The Florey Institute of Neuroscience and Mental Health

#ionis #rogcon ... See MoreSee Less

Antisense oligonucleotide therapy for SCN2A gain-of-function epilepsy

www.biorxiv.org

The clinical spectrum associated with SCN2A de novo mutations (DNMs) continues to expand and includes autism spectrum disorder with or without seizures, in addition to early and late seizure onset dev...

View on Facebook